AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
September 2020
Antioxidants

Younger red wine ‘more beneficial’ than aged wines, study finds

Younger red wines are likely to be more beneficial than aged wines, a study from Australia has found, due to the significant decrease in healthy antioxidants in wine over time.
The study, conducted by Australian’s Central Queensland’s CQ University and published in the Australian Journal of Grape and Wine Research, looked at 16 wines from Australia and New Zealand that ranged in age from one to six years old, to see the effect of ageing on trans-resveratrol, a naturally occurring antioxidant in grapes and red wine that has been proven to have cardiovascular, anti-inflammatory, and anti-diabetic effects.
The researchers expected the concentration of free trans‐resveratrol in wine to increase with storage because of hydrolysis of the resveratrol (the chemical breakdown of the biocompound as it reacts with water), however after researchers tested the wines at the start of the study and again after 16 months storage, they found that concentrations of trans‐resveratrol in the wine had decreased by an average of 76% over time, with decay rate proving independent of the growing conditions or year of vintage.
The researchers say that the data suggests that transformation of trans‐ to cis‐resveratrol takes place due to residual enzymatic activity (rather than being catalysed by light or acid). In general, this may reduce the anticipated health benefits of the wine given that cis‐resveratrol displays fewer health benefits than the trans isomer.
Source: Naiker, M., Anderson, S., Johnson, J., Mani, J., Wakeling, L. and Bowry, V. (2020), Loss of trans‐resveratrol during storage and ageing of red wines.
Australian Journal of Grape and Wine Research.
doi.org/10.35946/arcr.v40.2.12
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Methodology

& alcohol

Latest articles

Associations between beer, wine, and spirits consumption and major mortality outcomes in Norwegian men and women

Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study

A large randomised trial assessing alcohol cessation versus moderation on clinical events: UNATI

The impact of alcohol consumption on bone mineral density

Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions

Aim Digest

October 2026

September 2026

June 2026

May 2026

April 2026

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy